Hubei Kailong Chemical Group Co., Ltd.

SZSE:002783 Stock Report

Market Cap: CN¥3.9b

Hubei Kailong Chemical Group Past Earnings Performance

Past criteria checks 2/6

Hubei Kailong Chemical Group has been growing earnings at an average annual rate of 18.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 16.6% per year. Hubei Kailong Chemical Group's return on equity is 5.7%, and it has net margins of 3.2%.

Key information

18.1%

Earnings growth rate

16.3%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate16.6%
Return on equity5.7%
Net Margin3.2%
Next Earnings Update25 Apr 2025

Recent past performance updates

Investors Shouldn't Be Too Comfortable With Hubei Kailong Chemical Group's (SZSE:002783) Earnings

May 01
Investors Shouldn't Be Too Comfortable With Hubei Kailong Chemical Group's (SZSE:002783) Earnings

Recent updates

Hubei Kailong Chemical Group (SZSE:002783) Hasn't Managed To Accelerate Its Returns

Nov 11
Hubei Kailong Chemical Group (SZSE:002783) Hasn't Managed To Accelerate Its Returns

Investors Shouldn't Be Too Comfortable With Hubei Kailong Chemical Group's (SZSE:002783) Earnings

May 01
Investors Shouldn't Be Too Comfortable With Hubei Kailong Chemical Group's (SZSE:002783) Earnings

Even With A 28% Surge, Cautious Investors Are Not Rewarding Hubei Kailong Chemical Group Co., Ltd.'s (SZSE:002783) Performance Completely

Mar 06
Even With A 28% Surge, Cautious Investors Are Not Rewarding Hubei Kailong Chemical Group Co., Ltd.'s (SZSE:002783) Performance Completely

Revenue & Expenses Breakdown

How Hubei Kailong Chemical Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002783 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,63411849886
30 Jun 243,70612848685
31 Mar 243,67017346575
31 Dec 233,77917545080
30 Sep 233,63114444176
30 Jun 233,48812542380
31 Mar 233,5039739772
01 Jan 233,40613339666
30 Sep 223,252-26844864
30 Jun 223,082-30543548
31 Mar 222,896-33543348
01 Jan 222,759-39541345
30 Sep 212,7762036345
30 Jun 212,6085134541
31 Mar 212,3706029233
31 Dec 202,0115027530
30 Sep 201,7562029336
30 Jun 201,723732839
31 Mar 201,7052236645
01 Jan 201,8915037251
30 Sep 191,9207336649
30 Jun 191,9248333946
31 Mar 191,9148432551
31 Dec 181,8658232740
30 Sep 181,67912029240
30 Jun 181,54211626760
31 Mar 181,43810728841
31 Dec 171,35911528641
30 Sep 171,27612028928
30 Jun 171,1521242800
31 Mar 171,0231112630
31 Dec 169541092450
30 Sep 169071132260
30 Jun 169181062250
31 Mar 168911031950
31 Dec 15891981910
31 Mar 158991002230
31 Dec 148841071850

Quality Earnings: 002783 has high quality earnings.

Growing Profit Margin: 002783's current net profit margins (3.2%) are lower than last year (4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002783's earnings have grown by 18.1% per year over the past 5 years.

Accelerating Growth: 002783's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002783 had negative earnings growth (-18.6%) over the past year, making it difficult to compare to the Chemicals industry average (-5.4%).


Return on Equity

High ROE: 002783's Return on Equity (5.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/03 10:47
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hubei Kailong Chemical Group Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xi LiuHuatai Research